AFATINIB Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description A quinazoline compound having a 3-chloro-4-fluoroanilino group at the 4-position, a 4-dimethylamino-trans-but-2-enamido group at the 6-position, and an (S)-tetrahydrofuran-3-yloxy group at the 7-position. Used (as its dimaleate salt) for the first-line treatment of patients with metastatic non-small cell lung cancer. (Chemical Entities of Biological Interest Ontology, CHEBI_61390)
External Link https://dgidb.org/results?searchType=drug&searchTerms=AFATINIB
Similar Terms
Downloads & Tools

Genes

20 interacting proteins for the AFATINIB drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
NUP62 nucleoporin 62kDa 1.7644
DVL2 dishevelled segment polarity protein 2 1.7644
ARF1 ADP-ribosylation factor 1 1.7644
UHRF1 ubiquitin-like with PHD and ring finger domains 1 1.7644
KMT2D lysine (K)-specific methyltransferase 2D 1.05864
EGFR epidermal growth factor receptor 0.854915
ERBB2 erb-b2 receptor tyrosine kinase 2 0.315398
NF1 neurofibromin 1 0.211728
ERBB3 erb-b2 receptor tyrosine kinase 3 0.182524
EML4 echinoderm microtubule associated protein like 4 0.172604
ERBB4 erb-b2 receptor tyrosine kinase 4 0.134573
NR1I2 nuclear receptor subfamily 1, group I, member 2 0.08822
KRAS Kirsten rat sarcoma viral oncogene homolog 0.0650803
AKT1 v-akt murine thymoma viral oncogene homolog 1 0.0645512
NRG1 neuregulin 1 0.0630143
ALK anaplastic lymphoma receptor tyrosine kinase 0.0592522
PTEN phosphatase and tensin homolog 0.0515571
ROS1 ROS proto-oncogene 1 , receptor tyrosine kinase 0.0508961
BRAF B-Raf proto-oncogene, serine/threonine kinase 0.04812
PIK3CA phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha 0.0187702